| Issue |
E3S Web Conf.
Volume 233, 2021
2020 2nd International Academic Exchange Conference on Science and Technology Innovation (IAECST 2020)
|
|
|---|---|---|
| Article Number | 02025 | |
| Number of page(s) | 5 | |
| Section | BFS2020-Biotechnology and Food Science | |
| DOI | https://doi.org/10.1051/e3sconf/202123302025 | |
| Published online | 27 January 2021 | |
Clinical Effect of Ozagrel Sodium Combined with Eureklin on Acute Cerebral Infarction
Zhaotong Health Vocational Colleage 657000
a ZTWXXGC@126.com
b 13648703686@139.com
Cerebral infarction, as a serious cerebrovascular event, can lead to symptoms of various neurological disorders. The disability rate, mortality rate and recurrence rate are also very high, which is the health and economic burden of individuals, families and even human society. In this paper, 60 patients with cerebral infarction treated in our hospital were divided into observation group and control group. The observation group was treated with Ozagrel sodium combined with Eureklin, and the control group was given a single Ozagrel regimen The results showed that Ozagrel sodium combined with Yuclin was effective in the treatment of acute cerebral infarction.
© The Authors, published by EDP Sciences 2021
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.